Bawisan, Nida R.
HRN: 27-05-43 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/30/2025
CEFTAZIDIME 1GM (VIAL)
04/30/2025
05/07/2025
IV
1g
Q8
DM Foot, Left
Waiting Final Action